Equity

Profit & Loss Home > Equity > Corporate Information > Profit & Loss

Kopran LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524280 P/E (TTM) :37.44
ISIN Demat:INE082A01010 Div & Yield %:1.15 EPS (TTM) :6.96
Book Value (RS) :92.746276 Market Cap (Rs Cr.):1258.32 Face Value (RS) :10
    Change Company 
(Rs In Cr)
 Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
INCOME :      
Sales Turnover 305.65271.01337.46273.09204.52222.83
Excise Duty0.000.000.000.000.000.00
Net Sales305.65271.01337.46273.09204.52222.83
Other Income 2.005.9016.7116.098.0310.41
Stock Adjustments -3.791.841.74-3.553.93-14.70
Total Income303.86278.75355.91285.63216.48218.54
EXPENDITURE :      
Raw Materials 166.35159.22231.89174.14131.75123.04
Power & Fuel Cost9.698.597.897.586.515.68
Employee Cost 32.9430.0225.6125.1521.0518.34
Other Manufacturing Expenses 14.1012.5612.4510.699.758.33
Selling & Administrative Expenses 24.4621.3522.4520.8522.6519.79
Miscellaneous Expenses 6.752.461.983.231.312.75
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure254.29234.19302.26241.63193.03177.93
Operating Profit49.5844.5653.6444.0023.4440.62
Interest 4.203.774.502.672.953.81
Gross Profit45.3840.7949.1441.3320.4936.81
Depreciation4.985.004.624.414.324.10
Profit Before Tax40.4035.7944.5236.9216.1732.71
Tax9.048.6310.085.873.755.76
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.960.31-0.20-0.210.673.48
Reported Net Profit30.4026.8634.6431.2511.7423.47
Extraordinary Items 0.000.00-0.010.000.00-0.01
Adjusted Net Profit30.4026.8634.6531.2511.7423.48
Adjustment below Net Profit 0.410.060.000.000.000.00
P & L Balance brought forward111.8399.3879.2062.4157.1540.17
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 14.4914.4614.4614.466.496.49
P & L Balance carried down128.15111.8399.3879.2062.4157.15
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %30.0030.0030.0030.0030.0030.00
Dividend Per Share(Rs)3.003.003.003.003.003.00
Earnings Per Share-Unit Curr6.305.567.186.482.445.43
Earnings Per Share(Adj)-Unit Curr6.305.567.186.482.445.43
Book Value-Unit Curr92.7589.3586.4782.0578.5657.07
Book Value(Adj)-Unit Curr92.7589.3586.4782.0578.5657.07
Wednesday, September 16, 2026 12:00:00 AM
Adani Ports1725.95comprofit(0.85)%
      
Asian Paints2419.00comprofit(0.46)%
      
Axis Bank1243.95comprofit(1.93)%
      
Bajaj Finance1008.50comprofit(-0.12)%
      
Bajaj Finserv1839.60comprofit(-0.99)%
      
Bharat Electro..386.40comprofit(1.42)%
      
Bharti Airtel1837.00comprofit(0.38)%
      
Eternal316.80comprofit(0.38)%
      
HCL Technologi..1251.15comprofit(-0.31)%
      
HDFC Bank722.40comprofit(0.75)%
      
Hind. Unilever1963.50comprofit(1.21)%
      
ICICI Bank1359.00comprofit(0.52)%
      
Infosys1060.65comprofit(-1.43)%
      
Interglobe Avi..4744.00comprofit(-0.70)%
      
ITC264.35comprofit(2.46)%
      
Kotak Mah. Ban..414.90comprofit(1.29)%
      
Larsen & Toubr..3819.50comprofit(-0.79)%
      
M & M3073.95comprofit(1.45)%
      
Maruti Suzuki12189.80comprofit(-0.61)%
      
NTPC327.00comprofit(-0.91)%
      
Power Grid Cor..263.50comprofit(0.00)%
      
Reliance Indus..1241.40comprofit(0.44)%
      
SBI991.10comprofit(2.24)%
      
Sun Pharma.Ind..1853.50comprofit(1.01)%
      
Tata Steel182.85comprofit(-0.30)%
      
TCS2191.50comprofit(-2.60)%
      
Tech Mahindra1555.15comprofit(-1.26)%
      
Titan Company4914.95comprofit(1.34)%
      
Trent2772.20comprofit(1.51)%
      
UltraTech Cem.10720.00comprofit(-0.28)%
      

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)